Cargando…
Latamoxef-induced severe thrombocytopenia during the treatment of pulmonary infection: A case report
BACKGROUND: Latamoxef shows excellent antibacterial activity against anaerobic bacteria such as Bacteroides fragilis. Reports of thrombocytopenic toxicity of latamoxef are limited. This report presents a case of severe thrombocytopenia possibly induced by latamoxef, an infrequent adverse drug reacti...
Autores principales: | Zhang, Ruo-Ying, Zhang, Jun-Jie, Li, Jin-Meng, Xu, Ying-Ying, Xu, Yue-Huan, Cai, Xin-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372850/ https://www.ncbi.nlm.nih.gov/pubmed/36158491 http://dx.doi.org/10.12998/wjcc.v10.i22.7906 |
Ejemplares similares
-
Clinical ineffectiveness of latamoxef for Stenotrophomonas maltophilia infection
por: Hagiya, Hideharu, et al.
Publicado: (2015) -
Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children
por: Wang, Yang, et al.
Publicado: (2022) -
Latamoxef for Neonates With Early-Onset Neonatal Sepsis: A Study Protocol for a Randomized Controlled Trial
por: Qi, Hui, et al.
Publicado: (2021) -
Antiviral Treatment Options for Severe Fever with Thrombocytopenia Syndrome Infections
por: Zhang, Yin, et al.
Publicado: (2022) -
The combination of salvianolic acid A with latamoxef completely protects mice against lethal pneumonia caused by methicillin-resistant Staphylococcus aureus
por: Mu, Dan, et al.
Publicado: (2020)